Anthem Company Profile (NYSE:ANTM)

About Anthem (NYSE:ANTM)

Anthem logoAnthem, Inc. is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products. It also provides an array of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs and other administrative services. It provides an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits and radiology benefit management.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Managed Health Care
  • Sub-Industry: Managed Health Care
  • Symbol: NYSE:ANTM
  • CUSIP: 94973V10
  • Web:
  • Market Cap: $48.02 billion
  • Outstanding Shares: 262,584,000
Average Prices:
  • 50 Day Moving Avg: $191.59
  • 200 Day Moving Avg: $182.25
  • 52 Week Range: $114.85 - $198.98
  • Trailing P/E Ratio: 17.29
  • Foreward P/E Ratio: 14.06
  • P/E Growth: 1.22
Sales & Book Value:
  • Annual Revenue: $88.03 billion
  • Price / Sales: 0.55
  • Book Value: $100.46 per share
  • Price / Book: 1.82
  • Annual Dividend: $2.80
  • Dividend Yield: 1.5%
  • EBIDTA: $5.75 billion
  • Net Margins: 3.24%
  • Return on Equity: 12.93%
  • Return on Assets: 4.96%
  • Debt-to-Equity Ratio: 0.57%
  • Current Ratio: 1.65%
  • Quick Ratio: 1.65%
  • Average Volume: 1.47 million shs.
  • Beta: 0.7
  • Short Ratio: 4.48

Frequently Asked Questions for Anthem (NYSE:ANTM)

What is Anthem's stock symbol?

Anthem trades on the New York Stock Exchange (NYSE) under the ticker symbol "ANTM."

How often does Anthem pay dividends? What is the dividend yield for Anthem?

Anthem declared a quarterly dividend on Wednesday, July 26th. Stockholders of record on Friday, September 8th will be given a dividend of $0.70 per share on Monday, September 25th. This represents a $2.80 annualized dividend and a dividend yield of 1.53%. The ex-dividend date is Thursday, September 7th. This is a positive change from Anthem's previous quarterly dividend of $0.65. View Anthem's Dividend History.

How were Anthem's earnings last quarter?

Anthem, Inc. (NYSE:ANTM) posted its quarterly earnings data on Wednesday, July, 26th. The company reported $3.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.23 by $0.14. The business had revenue of $22.20 billion for the quarter, compared to the consensus estimate of $22.25 billion. Anthem had a net margin of 3.24% and a return on equity of 12.93%. The business's revenue was up 4.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $3.33 EPS. View Anthem's Earnings History.

When will Anthem make its next earnings announcement?

Anthem is scheduled to release their next quarterly earnings announcement on Wednesday, October, 25th 2017. View Earnings Estimates for Anthem.

Where is Anthem's stock going? Where will Anthem's stock price be in 2017?

18 equities research analysts have issued twelve-month price objectives for Anthem's stock. Their predictions range from $132.00 to $228.00. On average, they anticipate Anthem's share price to reach $180.06 in the next year. View Analyst Ratings for Anthem.

What are analysts saying about Anthem stock?

Here are some recent quotes from research analysts about Anthem stock:

  • 1. According to Zacks Investment Research, "Anthem’s shares have outperformed the industry in last one year. The company’s diverse product portfolio has helped in improving underwriting results. Anthem’s strategic acquisitions, divestitures and ACO arrangements further pave the way for long-term growth. Its rising level of medical membership continues to boost the top line. Its strong capital position backs effective capital deployment. Its frequent share buyback programs and regular dividend payments primarily aim at enhancing shareholders’ value. The company has seen the Zacks Consensus Estimate for 2017 and 2018 earnings being revised upward over the last 60 days. Followed by strong results in first half of 2017, the company has raised the earnings and revenue guidance for 2017." (9/20/2017)
  • 2. Cantor Fitzgerald analysts commented, "This morning, Anthem reported 2Q17 results. Revenue was essentially in line with expectations while adjusted EPS of $3.37 compares to our estimate of $2.90 and FactSet consensus of $3.24." (7/26/2017)

Who are some of Anthem's key competitors?

Who are Anthem's key executives?

Anthem's management team includes the folowing people:

  • Joseph R. Swedish, Chairman of the Board, President, Chief Executive Officer
  • John E. Gallina, Chief Financial Officer, Executive Vice President
  • Jose D. Tomas, Chief Human Resource Officer, Executive Vice President
  • Jacquelyn H. Wolf, Chief Human Resource Officer, Executive Vice President
  • Gloria M. McCarthy, Executive Vice President, Chief Administrative Officer
  • Thomas C. Zielinski, Executive Vice President, General Counsel
  • Brian T. Griffin, Executive Vice President, President - Commercial and Specialty Business
  • Peter D. Haytaian, Executive Vice President, President of Government Business Division
  • Craig E. Samitt M.D., Executive Vice President and Chief Clinical Officer
  • Ronald W. Penczek, Senior Vice President, Chief Accounting Officer, Controller

Who owns Anthem stock?

Anthem's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (8.64%), Vanguard Group Inc. (6.78%), State Street Corp (4.28%), FMR LLC (3.83%), Baillie Gifford & Co. (1.89%) and Orbis Allan Gray Ltd (1.62%). Company insiders that own Anthem stock include Gloria M Mccarthy, Jose D Tomas, Joseph Swedish, Julie A Hill, Ramiro G Peru, Ronald W Penczek, Thomas C Zielinski and William J Ryan. View Institutional Ownership Trends for Anthem.

Who sold Anthem stock? Who is selling Anthem stock?

Anthem's stock was sold by a variety of institutional investors in the last quarter, including Dodge & Cox, FMR LLC, Hotchkis & Wiley Capital Management LLC, Nordea Investment Management AB, OZ Management LP, Glenview Capital Management LLC, Bank of Nova Scotia and Renaissance Technologies LLC. Company insiders that have sold Anthem stock in the last year include Gloria M Mccarthy, Jose D Tomas, Joseph Swedish, Julie A Hill, Ramiro G Peru, Ronald W Penczek and Thomas C Zielinski. View Insider Buying and Selling for Anthem.

Who bought Anthem stock? Who is buying Anthem stock?

Anthem's stock was bought by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, JPMorgan Chase & Co., Tesco Pension Investment Ltd, UBS Asset Management Americas Inc., BlueMountain Capital Management LLC, Vanguard Group Inc., Parametric Portfolio Associates LLC and Prudential Financial Inc.. View Insider Buying and Selling for Anthem.

How do I buy Anthem stock?

Shares of Anthem can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Anthem's stock price today?

One share of Anthem stock can currently be purchased for approximately $182.86.

MarketBeat Community Rating for Anthem (NYSE ANTM)
Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  436 (Vote Outperform)
Underperform Votes:  493 (Vote Underperform)
Total Votes:  929
MarketBeat's community ratings are surveys of what our community members think about Anthem and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Anthem (NYSE:ANTM) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 9 Hold Ratings, 9 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $180.06 (1.53% downside)

Analysts' Ratings History for Anthem (NYSE:ANTM)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/21/2017Cowen and CompanyReiterated RatingBuy$160.00LowView Rating Details
9/20/2017Cantor FitzgeraldReiterated RatingBuy$215.00LowView Rating Details
8/20/2017Jefferies Group LLCReiterated RatingHold$204.00MediumView Rating Details
8/17/2017Morgan StanleyBoost Price TargetEqual Weight$196.00 -> $201.00LowView Rating Details
7/14/2017Bank of America CorporationBoost Price TargetBuy$224.00 -> $228.00LowView Rating Details
7/13/2017Deutsche Bank AGBoost Price TargetHold$173.00 -> $185.00LowView Rating Details
7/12/2017Credit Suisse GroupInitiated CoverageNeutral -> Neutral$195.00LowView Rating Details
6/28/2017Citigroup Inc.Reiterated RatingBuy$205.00LowView Rating Details
4/28/2017Sanford C. BernsteinBoost Price TargetOutperform$202.00 -> $212.00LowView Rating Details
4/27/2017Royal Bank Of CanadaReiterated RatingOutperform -> Outperform$179.00 -> $183.00LowView Rating Details
2/2/2017Barclays PLCBoost Price TargetEqual Weight$159.00 -> $169.00N/AView Rating Details
1/4/2017Piper Jaffray CompaniesInitiated CoverageNeutral$151.00N/AView Rating Details
1/4/2017Stifel NicolausDowngradeBuy -> Hold$143.24 -> $155.00N/AView Rating Details
12/1/2016Wells Fargo & CompanyUpgradeMarket Perform -> OutperformN/AView Rating Details
11/22/2016Wolfe ResearchUpgradeMarket Perform -> Outperform$173.00N/AView Rating Details
11/3/2016Leerink SwannBoost Price TargetOutperform$155.00 -> $160.00N/AView Rating Details
10/17/2016J P Morgan Chase & CoDowngradeOverweight -> Neutral$154.00 -> $132.00N/AView Rating Details
9/22/2016Evercore ISIInitiated CoverageHold$133.00N/AView Rating Details
8/15/2016FBR & CoReiterated RatingMarket Perform$155.00N/AView Rating Details
7/27/2016WedbushReiterated RatingNeutral$150.00N/AView Rating Details
5/24/2016Sterne Agee CRTDowngradeBuy -> NeutralN/AView Rating Details
4/28/2016Oppenheimer Holdings, Inc.Reiterated RatingBuyN/AView Rating Details
4/8/2016Cleveland ResearchInitiated CoverageBuy$170.00N/AView Rating Details
4/1/2016Goldman Sachs Group, Inc. (The)Boost Price TargetBuy$160.00 -> $170.00N/AView Rating Details
10/29/2015BMO Capital MarketsLower Price TargetMarket Perform$175.00 -> $155.00N/AView Rating Details
(Data available from 9/22/2015 forward)


Earnings History for Anthem (NYSE:ANTM)
Earnings by Quarter for Anthem (NYSE:ANTM)
Earnings History by Quarter for Anthem (NYSE ANTM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/25/2017$2.40N/AView Earnings Details
7/26/2017Q2 2017$3.23$3.37$22.25 billion$22.20 billionViewN/AView Earnings Details
4/26/2017Q1 2017$3.85$4.68$21.23 billion$22.32 billionViewN/AView Earnings Details
2/1/2017Q416$1.61$1.76$20.96 billion$21.50 billionViewListenView Earnings Details
11/2/2016Q316$2.47$2.45$20.77 billion$21.13 billionViewListenView Earnings Details
7/27/2016Q216$3.23$3.33$20.53 billion$21.27 billionViewListenView Earnings Details
4/27/2016Q116$3.32$3.46$19.86 billion$20.30 billionViewListenView Earnings Details
1/27/2016Q415$1.20$1.14$19.89 billion$20.02 billionViewListenView Earnings Details
10/28/2015Q315$2.33$2.73$19.63 billion$19.77 billionViewListenView Earnings Details
7/29/2015Q215$2.75$3.10$19.64 billion$19.80 billionViewListenView Earnings Details
4/29/2015Q115$2.69$3.14$19.36 billion$18.85 billionViewListenView Earnings Details
1/28/2015Q414$1.72$1.73$18.99 billion$18.78 billionViewListenView Earnings Details
10/29/2014Q314$2.28$2.36$18.72 billion$18.40 billionViewListenView Earnings Details
7/30/2014Q214$2.28$2.44$18.25 billion$18.23 billionViewListenView Earnings Details
4/30/2014Q114$2.12$2.30$17.96 billion$17.65 billionViewListenView Earnings Details
1/29/2014Q413$0.87$0.87$17.75 billion$17.60 billionViewListenView Earnings Details
10/23/2013Q313$1.79$2.10$17.63 billion$17.70 billionViewListenView Earnings Details
7/24/2013Q2 2013$2.09$2.60$17.89 billion$17.60 billionViewListenView Earnings Details
4/24/2013Q1 2013$2.38$2.94$18.03 billion$17.55 billionViewListenView Earnings Details
1/23/2013Q4 2012$0.94$1.03$15.23 billion$15.54 billionViewListenView Earnings Details
11/7/2012Q312$1.84$2.09$15.31 billion$15.13 billionViewN/AView Earnings Details
7/25/2012$2.07$2.04ViewN/AView Earnings Details
4/25/2012$2.26$2.34ViewN/AView Earnings Details
1/25/2012$1.12$0.99ViewN/AView Earnings Details
10/26/2011$1.68$1.77ViewN/AView Earnings Details
7/27/2011$1.80$1.83ViewN/AView Earnings Details
4/27/2011$1.87$2.35ViewN/AView Earnings Details
1/26/2011$1.23$1.33ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Anthem (NYSE:ANTM)
Current Year EPS Consensus Estimate: $11.83 EPS
Next Year EPS Consensus Estimate: $13.01 EPS


Current Dividend Information for Anthem (NYSE:ANTM)
Next Dividend:9/25/2017
Annual Dividend:$2.80
Dividend Yield:1.53%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:26.52% (Trailing 12 Months of Earnings)
23.67% (Based on This Year's Estimates)
21.52% (Based on Next Year's Estimates)
Track Record:2 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for Anthem (NYSE:ANTM)

Dividend History by Quarter for Anthem (NYSE ANTM)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Anthem (NYSE:ANTM)
Insider Ownership Percentage: 0.36%
Institutional Ownership Percentage: 87.65%
Insider Trades by Quarter for Anthem (NYSE:ANTM)
Institutional Ownership by Quarter for Anthem (NYSE:ANTM)
Insider Trades by Quarter for Anthem (NYSE:ANTM)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/1/2017Joseph SwedishInsiderSell21,125$197.00$4,161,625.00View SEC Filing  
8/10/2017Julie A HillDirectorSell524$190.80$99,979.20View SEC Filing  
8/10/2017Thomas C ZielinskiEVPSell9,127$191.25$1,745,538.75View SEC Filing  
6/7/2017Ronald W PenczekSVPSell867$187.46$162,527.82View SEC Filing  
5/30/2017Ramiro G PeruDirectorSell2,681$181.58$486,815.98View SEC Filing  
5/24/2017Julie A HillDirectorSell555$180.56$100,210.80View SEC Filing  
4/3/2017Gloria M MccarthyEVPSell15,187$166.38$2,526,813.06View SEC Filing  
3/6/2017Ronald W PenczekSVPSell729$165.56$120,693.24View SEC Filing  
3/2/2017Ronald W PenczekSVPSell1,213$166.56$202,037.28View SEC Filing  
3/2/2017Thomas C ZielinskiEVPSell22,936$166.29$3,814,027.44View SEC Filing  
1/9/2017Jose D TomasEVPSell6,500$142.92$928,980.00View SEC Filing  
12/12/2016Joseph SwedishInsiderSell8,176$144.10$1,178,161.60View SEC Filing  
11/22/2016Ronald W PenczekSVPSell820$138.29$113,397.80View SEC Filing  
11/11/2016Joseph SwedishInsiderSell24,513$131.48$3,222,969.24View SEC Filing  
8/10/2016Thomas C ZielinskiEVPSell5,254$128.83$676,872.82View SEC Filing  
8/3/2016Ronald W PenczekSVPSell552$128.37$70,860.24View SEC Filing  
8/1/2016Gloria M MccarthyEVPSell4,186$130.39$545,812.54View SEC Filing  
7/28/2016William J RyanDirectorSell3,125$133.15$416,093.75View SEC Filing  
7/11/2016Joseph SwedishCEOSell8,171$131.49$1,074,404.79View SEC Filing  
7/1/2016Gloria M MccarthyEVPSell4,786$131.23$628,066.78View SEC Filing  
6/29/2016Ramiro G PeruDirectorSell3,125$130.00$406,250.00View SEC Filing  
6/1/2016Gloria M MccarthyEVPSell4,786$131.69$630,268.34View SEC Filing  
6/1/2016Joseph SwedishCEOSell11,628$132.02$1,535,128.56View SEC Filing  
5/2/2016Gloria M MccarthyEVPSell4,786$141.02$674,921.72View SEC Filing  
5/2/2016Joseph SwedishCEOSell11,626$141.19$1,641,474.94View SEC Filing  
4/14/2016Gloria M MccarthyEVPSell4,786$142.26$680,856.36View SEC Filing  
4/1/2016Joseph SwedishCEOSell11,626$139.38$1,620,431.88View SEC Filing  
3/11/2016Gloria M MccarthyEVPSell7,557$139.73$1,055,939.61View SEC Filing  
1/28/2016Joseph SwedishCEOSell11,626$129.47$1,505,218.22View SEC Filing  
12/28/2015Joseph SwedishCEOSell11,626$139.47$1,621,478.22View SEC Filing  
9/8/2015Wayne S. DeveydtCFOSell6,969$144.00$1,003,536.00View SEC Filing  
6/1/2015Ramiro G PeruDirectorSell4,709$167.91$790,688.19View SEC Filing  
5/28/2015William J RyanDirectorSell4,709$163.58$770,298.22View SEC Filing  
4/13/2015Gloria M MccarthyEVPSell43,933$155.02$6,810,493.66View SEC Filing  
3/3/2015John E GallinaCAOSell39,556$145.30$5,747,486.80View SEC Filing  
12/8/2014Wayne S DeveydtCFOSell4,404$127.72$562,478.88View SEC Filing  
10/13/2014Wayne S DeveydtCFOSell26,938$116.71$3,143,933.98View SEC Filing  
9/18/2014Kenneth R GouletEVPSell41,624$121.32$5,049,823.68View SEC Filing  
9/11/2014Samuel R Md NussbaumEVPSell20,000$120.00$2,400,000.00View SEC Filing  
9/9/2014Samuel R Md NussbaumEVPSell38,244$119.52$4,570,922.88View SEC Filing  
9/9/2014Wayne S DeveydtCFOSell4,404$120.00$528,480.00View SEC Filing  
9/8/2014Wayne S DeveydtCFOSell64,536$118.00$7,615,248.00View SEC Filing  
8/28/2014Samuel R Md NussbaumEVPSell40,000$116.05$4,642,000.00View SEC Filing  
8/27/2014Samuel R Md NussbaumEVPSell35,000$116.06$4,062,100.00View SEC Filing  
8/5/2014Wayne S DeveydtCFOSell30,000$110.95$3,328,500.00View SEC Filing  
1/31/2014George Schaefer, Jr.DirectorSell10,000$86.70$867,000.00View SEC Filing  
12/26/2013Richard ZoreticEVPSell20,000$91.79$1,835,800.00View SEC Filing  
12/13/2013John CannonEVPSell9,558$87.73$838,523.34View SEC Filing  
12/11/2013Gloria MccarthyEVPSell111,867$90.99$10,178,778.33View SEC Filing  
9/13/2013Samuel Md NussbaumEVPSell117,512$89.20$10,482,070.40View SEC Filing  
9/11/2013Samuel Md NussbaumEVPSell42,100$89.29$3,759,109.00View SEC Filing  
9/10/2013John CannonEVPSell13,799$87.33$1,205,066.67View SEC Filing  
9/5/2013Wayne S DeveydtCFOSell165,576$87.54$14,494,523.04View SEC Filing  
9/4/2013Randal L BrownEVPSell223,647$86.86$19,425,978.42View SEC Filing  
8/26/2013Warren JobeDirectorSell3,000$86.56$259,680.00View SEC Filing  
8/14/2013John CannonEVPSell114,336$86.95$9,941,515.20View SEC Filing  
8/6/2013Kenneth GouletEVPSell62,643$87.36$5,472,492.48View SEC Filing  
6/10/2013John CannonEVPSell97,759$78.27$7,651,596.93View SEC Filing  
6/5/2013William J RyanDirectorSell10,000$75.23$752,300.00View SEC Filing  
5/30/2013Lori A BeerEVPSell131,312$78.91$10,361,829.92View SEC Filing  
5/30/2013Warren Y JobeDirectorSell3,000$78.01$234,030.00View SEC Filing  
5/28/2013Lori A BeerEVPSell55,732$79.00$4,402,828.00View SEC Filing  
5/22/2013Gloria M MccarthyCAOSell33,919$78.71$2,669,764.49View SEC Filing  
2/25/2013George A Schaefer JrDirectorSell7,542$62.12$468,509.04View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Anthem (NYSE:ANTM)
Latest Headlines for Anthem (NYSE:ANTM)
DateHeadline logoAM Best Comments on Credit Ratings of Anthem, Inc. and Its Subsidiaries Following Acquisition Announcement - Business Wire (press release) - September 22 at 6:46 PM logoTop Stock Reports for Caterpillar, Texas Instruments & Alphabet - September 22 at 6:45 PM logoAnthem Agrees To Acquire HealthSun For Integrated Network - Seeking Alpha - September 22 at 1:44 PM logoFeatured Company News - Health Insurance Major Anthem Acquires Florida Based HealthSun - September 22 at 1:44 PM logoShould Value Investors Consider Anthem (ANTM) Stock Now? - September 22 at 1:44 PM logoAnthem to Boost Medicare in Florida With HealthSun Buyout - September 22 at 1:44 PM logoCowen and Company Reaffirms "Buy" Rating for Anthem, Inc. (ANTM) - September 21 at 4:28 PM logoAnthem, Inc. (ANTM) Earns "Buy" Rating from Cantor Fitzgerald - September 21 at 3:44 PM logoAnthem, Inc. (ANTM) Lifted to Buy at Zacks Investment Research - September 20 at 9:32 PM logoAnthem to Acquire HealthSun - September 20 at 9:29 PM logoTop Research Reports for Northrop Grumman, BNY Mellon & Celgene - September 20 at 9:29 PM logoAnthem to Acquire HealthSun - Business Wire (press release) - September 20 at 4:28 PM logo[$$] Anthem to Buy HealthSun From Group Led by Summit Partners - September 20 at 4:28 PM logoAnthem, Inc. (ANTM) Stock Rating Lowered by Zacks Investment Research - September 19 at 7:02 PM logoFeatured Company News - Anthem Will Offer Obamacare Health Plans in Virginia in 2018 - September 19 at 3:54 PM logoPublic Exchange Woes Hit Health Insurers: Stocks in Focus - September 19 at 3:54 PM logoZacks Investment Research Downgrades Anthem, Inc. (ANTM) to Hold - September 18 at 12:16 AM logoAnthem (ANTM) and Magellan Health (MGLN) Financial Review - September 17 at 4:26 AM logoAnthem, Inc. (ANTM) Lowered to "Hold" at BidaskClub - September 16 at 6:32 PM logoComparing Universal American (UAM) and Anthem (ANTM) - September 16 at 12:32 AM logoAnthem reverses itself, will stay in Virginia ACA exchange - Seeking Alpha - September 15 at 9:16 PM logoAnthem to sell Obamacare health plans in Virginia counties that don't offer them - Reuters - September 15 at 4:13 PM logoOne state just got saved from Obamacare's nightmare scenario - September 15 at 4:13 PM logo[$$] Anthem Reverses Decision to Pull Out of ACA Exchange in Virginia - September 15 at 4:13 PM logoAnthem, Inc. (ANTM) Earns Buy Rating from Cantor Fitzgerald - September 15 at 3:36 PM logoAnthem, Inc. – Value Analysis (NYSE:ANTM) : September 14, 2017 - September 14 at 9:46 PM logoAnthem, Inc. (ANTM) Upgraded at Zacks Investment Research - September 14 at 9:51 AM logoAnthem, Inc. breached its 50 day moving average in a Bearish Manner : ANTM-US : September 13, 2017 - September 13 at 5:02 PM logoAnthem Was the S&P 500’s Top Loser on September 12 - September 13 at 5:02 PM logoThe Biggest Loser: Anthem Drops 3.4% - September 12 at 9:10 PM logo3 Value Stocks in Health Insurance to Bet On - September 12 at 4:09 PM logoAnthem, Inc. (ANTM) - September 12 at 4:09 PM logoObamacare Heavyweight Anthem Considers Retreating From More States - September 12 at 4:09 PM logoAnthem still considering presence in some Obamacare markets: CEO - September 12 at 4:09 PM logoUniversal Health (UHS) Grows on Buyouts, Expenses a Drag - September 11 at 8:34 PM logoUniversal Health (UHS) Grows on Buyouts, Expenses a Drag - Nasdaq - September 11 at 3:32 PM logo Brokerages Anticipate Anthem, Inc. (ANTM) Will Post Quarterly Sales of $22.13 Billion - September 11 at 9:22 AM logoZacks Investment Research Upgrades Anthem, Inc. (ANTM) to Buy - September 10 at 5:52 PM logoZacks: Analysts Expect Anthem, Inc. (ANTM) Will Announce Earnings of $2.43 Per Share - September 9 at 11:50 AM logoAnthem Takes Action to Support Florida Ahead of Hurricane Irma - September 8 at 4:19 PM logoEquifax breach exposes 143 million people to identity theft - September 8 at 8:17 AM logoLast two individual health insurers in Kentucky significantly increase rates - September 7 at 8:56 PM logoAnthem still shrinking Obamacare footprint - Seeking Alpha - September 7 at 3:54 PM logo[$$] Obamacare Insurer in Virginia to Scale Back Planned Expansion - September 7 at 3:54 PM logoCertain Patients with Type 2 Diabetes Less Likely to Suffer Heart Failure While Taking New Class of Antidiabetic Drug - September 7 at 3:54 PM logoTriple-S Management Corporation (GTS) versus Anthem (ANTM) Financial Review - September 7 at 6:16 AM logoAnthem, Inc. (ANTM) Insider Sells $4,161,625.00 in Stock - September 6 at 7:40 PM logoAnthem, Inc. (ANTM) Lifted to "Buy" at BidaskClub - September 6 at 7:12 PM logoAnthem, Inc. (ANTM) Ex-Dividend Date Scheduled for September 07, 2017 - Nasdaq - September 6 at 3:51 PM logoAnthem To Scale Back Obamacare To Half Of Kentucky's Counties - September 6 at 3:51 PM



Anthem (ANTM) Chart for Friday, September, 22, 2017

This page was last updated on 9/22/2017 by Staff